文献速递肾移植

稳定期肾移植受者维生素D与K联合状态与长期结局的关系

Joint association of vitamins D and K status with long-term outcomes in stable kidney transplant recipients.
PubMed 文献 · Nephrol Dial Transplant · 2020-01-01

该研究纳入461例稳定期肾移植受者,随访中位9.8年,评估维生素D与K联合状态及维生素D治疗与全因死亡和 death-censored 移植物失功的关联。结果显示,维生素D与K双低状态与死亡风险(HR 2.33,95%CI 1.26-4.30)和移植物失功风险(HR 3.25,95%CI 1.17-9.08)升高相关;在维生素D治疗患者中,低维生素K状态与死亡和移植物失功风险强烈相关。

要点

  • 维生素D与K双低状态在稳定期肾移植受者中占26%。
  • 双低状态与全因死亡和移植物失功风险升高独立相关。
  • 接受维生素D治疗者中,低维生素K状态与不良结局风险强烈相关。

核心结论

  • 维生素D与K联合缺乏在稳定期肾移植受者中常见,且与死亡和移植物失功风险升高相关。
  • 在接受维生素D治疗的患者中,低维生素K状态与过早死亡和移植物失功风险强烈相关。

研究设计与样本

  • 单中心研究,纳入461例稳定期肾移植受者,移植后中位6.1年。
  • 基线检测25-羟基维生素D和去磷酸化未羧化基质Gla蛋白(dp-ucMGP),按25(OH)D <50/≥50 nmol/L和dp-ucMGP中位数<1057/≥1057 pmol/L分组。
  • 随访中位9.8年,观察全因死亡和death-censored移植物失功。

主要发现

  • 平均年龄52±12岁,122例(26%)存在维生素D与K双低状态。
  • 随访期间128例(28%)死亡,48例(10%)发生death-censored移植物失功。
  • 与25(OH)D≥50 nmol/L且dp-ucMGP<1057 pmol/L者相比,双低状态者死亡风险HR 2.33(95%CI 1.26-4.30),移植物失功风险HR 3.25(95%CI 1.17-9.08)。
  • dp-ucMGP每增加500 pmol/L,维生素D治疗者死亡风险HR 1.41(95%CI 1.08-1.41),无治疗者HR 1.07(95%CI 0.97-1.18)。
  • dp-ucMGP每增加500 pmol/L,维生素D治疗者移植物失功风险HR 1.71(95%CI 1.17-2.49),无治疗者HR 1.19(95%CI 1.05-1.36),交互作用P<0.07(维生素D治疗n=44)。

临床怎么用

  • 对稳定期肾移植受者应关注维生素D与K联合状态,双低状态提示不良结局风险升高。
  • 接受维生素D治疗的患者中,监测维生素K状态(dp-ucMGP)可能有助于风险分层。

局限性

  • 单中心研究,样本量有限,维生素D治疗亚组仅44例。
  • 观察性设计,无法确定因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Kidney transplant recipients (KTRs) experience substantial survival benefit compared with dialysis patients. However, their mortality and graft failure risk remain high. KTRs are often low in micronutrient status, including vitamins D and K. We investigated the association of both vitamins D and K status, and vitamin D treatment with all-cause mortality and death-censored graft failure. METHODS: We studied 461 KTRs from a single-centre study at median 6.1 years after transplantation. At baseline, vitamins D and K concentrations were measured by 25-hydroxyvitamin D [25(OH)D] and dephosphorylated uncarboxylated matrix gla protein (dp-ucMGP) and patients were categorized into: 25(OH)D <50/≥50 nmol/L and median dp-ucMGP <1057/≥1057 pmol/L. RESULTS: Mean age was 52 ± 12 years, and 122 KTRs (26%) had low vitamins D and K status. During median 9.8 years follow-up, 128 patients (28%) died and 48 (10%) developed death-censored graft failure. Low vitamins D and K status was associated with 2.33 (1.26-4.30) [hazard ratio (95% confidence interval)] increased mortality risk and 3.25 (1.17-9.08) increased graft failure risk compared with KTR with 25(OH)D ≥50 nmol/L and dp-ucMGP <1057 pmol/L. Dp-ucMGP was strongly associated with mortality (per 500 pmol/L increase): 1.41 (1.08-1.41) for vitamin D treatment versus no treatment 1.07 (0.97-1.18), and graft failure 1.71 (1.17-2.49) for vitamin D treatment versus 1.19 (1.05-1.36) no treatment, P-interaction <0.07 for vitamin D treatment (n = 44). CONCLUSIONS: Combined vitamins D and K deficiency are highly prevalent and are associated with increased mortality and graft failure risk compared with high vitamins D and K status. Low vitamin K status was strongly associated with an increased risk of premature mortality and graft failure for patients treated with vitamin D versus no vitamin D treatment.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. van Ballegooijen AJ, Beulens JWJ, Keyzer CA, et al. Joint association of vitamins D and K status with long-term outcomes in stable kidney transplant recipients. Nephrol Dial Transplant. 2020. PMID: 30753729. doi:10.1093/ndt/gfy399

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。